Cargando…

P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430757/
http://dx.doi.org/10.1097/01.HS9.0000972096.78746.85
_version_ 1785091042938191872
collection PubMed
description
format Online
Article
Text
id pubmed-10430757
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104307572023-08-17 P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430757/ http://dx.doi.org/10.1097/01.HS9.0000972096.78746.85 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title_full P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title_fullStr P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title_full_unstemmed P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title_short P1302: SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY
title_sort p1302: salvage allogeneic hematopoietic stem cell transplantation is also the curative and safe treatment for relapsed/refractory acute myeloid leukemia in the era of targeted therapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430757/
http://dx.doi.org/10.1097/01.HS9.0000972096.78746.85
work_keys_str_mv AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy
AT p1302salvageallogeneichematopoieticstemcelltransplantationisalsothecurativeandsafetreatmentforrelapsedrefractoryacutemyeloidleukemiaintheeraoftargetedtherapy